The in vitro effect of the diabetes-associated markers insulin, leptin and oxidative stress on cellular characteristics promoting breast cancer progression is GLUT1-dependent

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Cláudia Raquel Santos Silva

    Autor

  • João Tiago De Sousa Pinto Guimarães

    Autor

  • Maria De Fátima Moreira Martel

    Autor

Participantes de fora da FMUP

  • Andrade, N
  • Patricio, E

Unidades de investigação

Abstract

Obesity and type 2 diabetes mellitus (T2DM) associate with increased incidence and mortality from many cancers, including breast cancer. The mechanisms involved in this relation remain poorly understood. Our study aimed to investigate the in vitro effect of high levels of glucose, insulin, leptin, TNF-alpha, INF-gamma and oxidative stress (induced with tert-butylhydroperoxide (TBH)), which are associated with T2DM, upon glucose uptake by breast cancer (MCF-7 and MDA-MB-231) and non-cancer (MCF-12A) cells and to correlate this effect with their effects upon cellular characteristics associated with cancer progression (cell proliferation, viability, migration, angiogenesis and apoptosis). H-3-DG uptake was markedly inhibited by a selective GLUT1 inhibitor (BAY-876) in all cell lines, proving that H-3-DG uptake is mainly GLUT1-mediated. TBH (2.5 mu M), insulin (50 nM), leptin (500 ng/ml) and INF-y (100 ng/ml) stimulate GLUT1-mediated H-3-DG (1 mM) uptake by both ER-positive and triple-negative breast cancer cell lines. TBH and leptin, but not insulin and INF-gamma, increase GLUT1 mRNA levels. Insulin and leptin (in both ER-positive and triple-negative breast cancer cell lines) and TBH (in the triple-negative cell line) have a proproliferative effect and leptin possesses a cytoprotective effect in both breast cancer cell lines that can contribute to cancer progression. The effects of TBH, insulin, leptin and INF-gamma upon breast cancer cell proliferation and viability are GLUT1-dependent. In conclusion, T2DM-associated characteristics induce changes in GLUT1-mediated glucose uptake that can contribute to cancer progression. Moreover, we conclude that BAY-876 can be a strong candidate for development of a new effective anticancer agent against breast cancer.

Dados da publicação

ISSN/ISSNe:
0014-2999, 1879-0712

European Journal of Pharmacology  Elsevier

Tipo:
Article
Páginas:
-
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 15

Citações Recebidas na Scopus: 18

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • Type 2 diabetes mellitus; Breast cancer; Glucose transport; Insulin; Leptin; Oxidative stress

Financiamento

Proyectos asociados

The role of EGCG in breast cancer prevention and therapy

Investigador Principal: Maria de Fátima Moreira Martel

Estudo Clínico Académico (EGCG) . 2020

Intestinal fructose absorption: regulation and relation to human diseases

Investigador Principal: Maria de Fátima Moreira Martel

Estudo Clínico Académico . 2020

The role of the glutamine transporter ASCT2 in antineoplastic therapy

Investigador Principal: Maria de Fátima Moreira Martel

Estudo Clínico Académico . 2020

The effect of dietary polyphenols upon the intestinal absorption of fructose: relevance for metabolic syndrome

Investigador Principal: Maria de Fátima Moreira Martel

Estudo Clínico Académico . 2020

Citar a publicação

Partilhar a publicação